Molina Healthcare director receives stock grant

GROHOWSKI LEO P reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

GROHOWSKI LEO P reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Leo P. Grohowski received a grant of 237 shares of Common Stock on July 1, 2026 as compensation for his board service. The shares were issued under Molina Healthcare’s 2025 Equity Incentive Plan at a price of $232.55 per share, based on the closing market price that day.

This quarterly equity award represents one quarter of an annual director equity value of $220,000, with $55,000 granted each quarter. Following this grant, Grohowski directly holds 1,542 shares of Molina Healthcare common stock.

Insider Trade Summary

Grant/Award: 237 shares

Grant/Award 1 txn

Insider GROHOWSKI LEO P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	237	$232.55	$55K

Holdings After Transaction: Common Stock — 1,542 shares (Direct)

Footnotes (3)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.
3. F3. Represents the closing price of the Issuer's common stock on July 1, 2026.

Key Figures

Shares granted: 237 shares Grant price per share: $232.55 per share Quarterly equity award value: $55,000 +2 more

5 metrics

Shares granted 237 shares Quarterly director equity grant on July 1, 2026

Grant price per share $232.55 per share Closing price of common stock on July 1, 2026

Quarterly equity award value $55,000 One quarter of annual director equity award

Annual director equity award value $220,000 Aggregate dollar value per director

Shares held after transaction 1,542 shares Director’s direct holdings following the grant

Key Terms

2025 Equity Incentive Plan, annual equity award, Common Stock

3 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted..."

Common Stock financial

"The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Molina Healthcare (MOH) director Leo P. Grohowski report in this Form 4?

Leo P. Grohowski reported receiving 237 shares of Molina Healthcare common stock as a compensation grant. The award was issued under the 2025 Equity Incentive Plan and is part of his regular director equity compensation, rather than an open-market purchase or sale.

At what price was the Molina Healthcare (MOH) director stock grant calculated?

The 237-share grant was calculated using a price of $232.55 per share, equal to the closing price of Molina Healthcare common stock on July 1, 2026. This price was used to convert a $55,000 quarterly equity award into a share amount.

How large is Molina Healthcare (MOH) director Grohowski’s quarterly and annual equity award?

The filing states each director’s annual equity award is valued at $220,000, with one quarter, or $55,000, granted on the first day of each quarter. The July 1, 2026 grant of 237 shares reflects one such quarterly installment.

How many Molina Healthcare (MOH) shares does director Grohowski hold after this grant?

After receiving the 237-share grant, Leo P. Grohowski directly holds 1,542 shares of Molina Healthcare common stock. This total reflects his position immediately following the reported award and shows his ongoing equity stake as a board member.

Is the Molina Healthcare (MOH) Form 4 transaction a market buy or sell?

The transaction is a grant or award acquisition, not a market buy or sell. Shares were issued to the director under the 2025 Equity Incentive Plan as part of his board compensation, using the closing stock price to determine the number of shares granted.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:50 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GROHOWSKI LEO P

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A(1)		237(2)	A	$232.55(3)	1,542	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

3. Represents the closing price of the Issuer's common stock on July 1, 2026.

Remarks:

	Jeff D. Barlow, power of attorney for Leo Grohowski	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)